Smoking mice – possibilities and limitations for studying COPD

G. Brusselle (Ghent, Belgium)

Source: Annual Congress 2007 - Lunchtime programme: of mice, man and cell cultures - discussing different approaches in experimental lung research
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Brusselle (Ghent, Belgium). Smoking mice – possibilities and limitations for studying COPD. Annual Congress 2007 - Lunchtime programme: of mice, man and cell cultures - discussing different approaches in experimental lung research

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD
Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD
Year: 2011

What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018

Self-reported vs. observed functional limitations in COPD
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009

The Scandinavian approach to using data for studying the early risks and consequences of asthma
Source: International Congress 2019 – How do big data and classical epidemiology contribute to solving chronic respiratory ill health?
Year: 2019

Genome-based risk prediction of asthma and COPD: applicability and psychological issues
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012

The effects of long-term smoking on pre-existing asthma in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 253s
Year: 2004

Answering questions and challenges in the management of health smoking and COPD patients
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020

Recognising and addressing the psychosocial and behavioural aspects of COPD and asthma patients
Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases
Year: 2004

Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014

Potential usefulness of phenotyping in asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013

COPD – future prospects for women
Source: Eur Respir J 2006; 28: Suppl. 50, 447s
Year: 2006

Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011

COPD - Current challenges
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008

Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007